Intranasal and intramuscular H5-Matrix-M nanoparticle vaccines protects against highly pathogenic Influenza A (H5N1) virus in mice [dataset]

Published: 6 July 2026| Version 1 | DOI: 10.17632/x8b2f87c99.1
Contributors:
,
,
,
,
,
,
,
,

Description

In this work, we characterized the immunogenicity and efficacy of a Matrix-M®–adjuvanted nanoparticle protein vaccine containing recombinant H5 HA of A/American wigeon/South Carolina/22/000345-001/2021 virus (clade 2.3.4.4b, H5-MNP). Influenza A virus (H5N1) animal challenge model involves BL/6 mice and Madin-Darby Canine Kidney epithelial (MDCK) cells. Data types include Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) imputed values from Quant Studio, Focus-forming assay (FFA) values from CTL Biospot, histological images, and weight loss data.

Files

Steps to reproduce

Refer to the Methods sections of the open access manuscript.

Institutions

Categories

Immunology, Vaccine

Funders

Licence